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Summary: A double lumen catheter .wasdeveloped as an applicator for the remote 
afterloading system (RALS) of 60CO for the intracavitary irradiation of an obstructed com-
mon bi.1e duct due to gallbladder cancer in lcase and by cholangiocarcinoma in 7 cases. 
This Was fol1owed by the biliary endoprosthesis with expandable metallic stents to main-
tain patency. The mean survival period after treatment was not long (14 weeks). How同
ever， removal of the external drainage tube was possible in 7 of the 8 cases， and none of the 
8 cases showed dislodgement or deformity of the. stent， or obstruction of the bile duct in 
the stent同insertedarea. This combination effectively provided palliation， and has consid-
erable potential for malignant biliary obs.truction. 
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INTRODUCTION 
Intracavitary irradiation with a remote afterloading system (RALS) has been used 
for the treatment of cancer of the uterine cervix and the esophagus. On occasion， malig-
nantbiliary obstructionhas also been managecl by the placelllent ofhigh-dose-rateiridium 
wire sources with RALS into a common duct stent1). 
The expandable metallic stent has been devised to dilate stenotic tubular struc圃
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tures2)~5). 1t has been succ~ssfully employed in patients with ve~a caval and tra，che-
obronchial stenoses secondary to neoplasms as well as complications of surgery andfor 
radiation therapy. 
The combination of a new applicator for high回 dose-rateintracavitary irradiation of 
60CO source and expandable metallic stents as a biliary endoprosthesis is described for the 
treatment of patients with a ma~ignant biliary tra，ct obstruction. 
METHODS AND PATIENTS 
Applicator (Fig.la) 
The applicator (Cook 1nc.， Bloomington， 1N) is constructed as a double lumen 
catheter， 14 Fr outer diameter. One lumeh is a blind sac for the insertion of the source 
of irradiation， while the other allows the insertion of a 0.035 inchguide wire for introduc-
tion and exchange. 
Technique for insertion 
The placement of this applicator is simi1ar to that of any 14 Fr biliary stent. A peel 
a way catheter can also be used for the insertion. 
1rradiation 
External irradiation、wasdelivered by a linear accelerator (4MVX) with anterior-
posterior paral1el opposing portals. 
1ntracavitary irradiation using high-dose-rate remote afterloading system， RALS， 
(Ralstron 20B， Shimazu Company， Japan) was performed回 fol1ows(Fig. lb， lc， 3c): 
The applicator was exchanged with the external drainage tube. Next a dummy source 
of radiation was inserted into the applic乱torto determine the location and distribution of 
Irradiation dosage. Then， with the RALS， a 4 Ci 60CO source which delivers atproxi-
mately 0.14 Gyfsec at 1 cm was inserted. The irradiation was initiated andmoved in 
intervals of 1 cm. 
Expandable metallic stent (Fig.2a) 
The. expandable metallic stent is made of a stainless steel wire bent in a zigzag 
fashion with a certain frequency to make a cylindrical form. A bare stent is prepared by 
vertically connecting these wires to each other torresponding to the length of the lesion. 
1n addition， a nylon graft prepared by covering a bare stent with cylindrically formed 
mesh nylon was also used. 
Biliary endoprosthesis (Fig. 2b， 3f) 
For insertion of the expandable metal1ic stent， a Teflon introducer and a pusher are 
used. The introducer is inserted along the guide wire to a position sufficiently beyond 
the lesion. Then， the inner syringe and the guide wire are removed， and the stent is in田
serted and advanced through the outer syringe using the pusher. When the tip of 
the stent has passed the affected area， the pusher is fixed and the outer syririge is slowly 
removed. If done correctly， the stent gradual1y leaves the tip ofthe outer syringe and be-
gins to dilate， resulting in adherence and fixation of the stent to the bile duct wall. At 
this point， the stent insertion is completed. Subsequently， the outer syringe is exchanged 
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with an externaldrainage tube. The patient's condition is observed for about one week 
of external drainage and a氏erthe closure of the external drainage tube， and cholangio-
graphy is performedagain. After confirming the patency of the bile duct by cholangio・
graphy， the external drainage tube is removed and the procedure for biliary endoprosthesis 
is thereby completed. 
Patients Data (Table 1) 
Eight cases .of advanced biliary tract carcinoma in which obstruction of the extra同
hepaticbile duct had been seen and surgical treatment had been impossible (7 cases 
of cholangiocarcinoma and 1 case of gallbladder cancer) were treated. All of them had 
been diagnosed by cytology andfor diagnostic images (PTC， ERC， CT， US， angiogram 
etc.) as having malignant biliary obstruction. They consisted of 4 males and 4 females， 
with ages ranging from 45 to 76 years (mean: 62 years). Total dose of intracavitary 
irradiation was 30 to 40 Gy， which was deliver巴din 4 to 6 fractions at twice a we巴k. 1n 
seVen of these cases， external irradiation at a total dose of 30 to 32 Gy was additionally de-
livered before and after intracavitary irradiation. AI1 cases received biliary endoprosthesis 
with an expandable metallic stent within 1 to 2 weeks after irradiation. 
RESUL TS (Table 1) 
1n 8 cases， cholangiography was performed via the external drainage tube after 
intracavitary irradiation. This examination demonstrated that the obstructed bile duct 
recovered patency (the diameter of the lumen was 5 mm  or more) in al of the' 8 
cases. This finding suggests that the tumor can be locally controlled by intracavitary 
irradiation. After confirming the recovery of patency in the bile duct， an expandable 
metallic stent was inserted. After 1 to 2 weeks of external drainage， cholangiography 
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was performed via the externa1 drainage tube. This examination demonstraied no diト
10dgement of the st巴ntin any case and good passage of the contrast medium. 
In 7 of the 8 cases， the externa1 drainage tube cou1d be removed， allowing discharge 
from the hospital. The maximum duration of comp1ete endoprosthesis has been 17 
weeks， which is in the one surviving patient. Even in 4 patients who died， the duration 
of comp1ete endoprosthesis was 4 to 15 weeks (mean: 1 weeks). None of the cases 
showed dis10dgement or deformity of the stent， or obstruction of the stent附lns巴rtedarea 
of the bi1e duct. Autopsy was performed in 3 cases， in which the 1umen of th巴 stent
remained patent， and microscopically the area exposed to intracavitary irradiation and 
the stent-inserted area showed mar1王edfibrosis. Cancer cells were absent in the surface 
1ayers of the bi1e duct wall andfor sporadically seen on1y in the deep 1ayer. No serious 
comp1ications was seen in any case. 
Case 1 (Fig. 3) 
A 68同year困 01dwoman with jaudice due to obstruction of the common duct at the 
bifurction of the hepatic ducts caused by a gallb1adder cancer which infi1trated the right 
10be of the 1iver and the porta hepatis was treated by percutaneous transhepatic externa1-
interna1 bi1iary drainage with an 8.3 Fr catheter (Fig.3a). The patient de1ivered exter-
na1 irradiation (32 Gy 116 fractions) with a field of 5.0 cm X 6.0 cm at a d巴pthof 10 cm. 
During that period the drainage catheter was gradually di1ated up to 14 Fr (Fig， 3b). 
After externa1 irradiation， intracavitary irradiation was performed five times (twice a week 
for a tota1 dose of 37.5 Gy) at a distance of 6 cm， in such a manner as to obtain a dose of 
7.5 Gy at a site 1 cm from the center ofthe radiation source (Fig.3c). After irradiation， 
a ch01angiogram performed through the drainage catheter demonstrated the common bil巴
duct to have a smooth wall and a free flow of contrast materia1 to the duodenum (Fig. 3d). 
Three days after the 1ast irradiation， the ny10n-covered expandab1e metallic bi1iary 
endoprosthe由 (ny10ngraft) was p1aced in the common bi1e duct whi1e the trai1町 n
was 10cated in the common hepatic duct (Fig. 3f). At the time of introduction， the dia-
m巴terof the stent was 0.7 cm. Externa1 drairrage was maintained just proxima1 to the 
endoprosthesis for four days， at which time it was removed after patency was demonstrated 
by ch01angiography. The stents expanded to 1.1 cm in diameter; the 
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depth of 10 cm， using a linear accelerator (4MVX). After external irradiation， intracavi岡
taryirradiation was performed five times for a total dose of 32.5 Gy at a distance of 8 cm. 
A丘町 irradiation，a cholangiogram performed through the drainage catheter demonstrated 
the common bile duct to have a smooth wall and free flow of contrast material to the dlト
odenum (Fig.4b). One week after irradiation， the expandable metallic biliary endopros-
thesis (bare stent) was placed in the common bile duct (Fig.4c). External drainage was 
removed after patency was demonstrated by cholangiography. However， sixteen weeks 
later， peritonitis carcinomatosa worsened and the patient died. Postmortem histopathol-
ogical examination was performed. Retrograde cholangiogram from the papilla vater 
of the postmortem specimen demonstrated no obstruction of the stent-inserted area， and 
the passage to the intrahepatic bile duct was good (Fig. 4d). Macroscopic observation 
of the cross section showed that the patency of the inner lumen had been kept well， and 
that the stent wire was embedded in the wal1 (Fig.4e). Microscopically， the inner sur-
face ofthe lumen wher巴 thestent had been inserted was found to be covered with thick fi-
brous tissue; a small numb~r of cancer cells were seen only in the deep .layer and no 
cancer cells were found in the surface layer. 
DISCUSSION 
At diagnosis most malignant tumors complicated by biliary obstruction are too 
advanced for radical surgery. Bile duct drainage palliates jaundice but has litle effect 
on the length of survival. External radiation therapy or intra-operative irradiation has 
not been very effective6l~8l. When compared to external irradiation， intracavitary ir-
radiation has the potential to deliver a higher local dose. In the past， low-dose-rate 
intracavitary irradiation was performed using 192Ir or 226Ra9l~ !3). For low-dose~rate 
irradiation which involves long-term insertion of a radiation source; the patient needs 
to be kept in isolation for a long time. Therefore， a variety ofproblems (such as exposure 
of the operator to irradiation， drifting of the radiation source， infection， and physical and 
mental stess to the patient) can arise. These problems of low田 dose剛 rateirradiation have 
been solved sy 60CO high-dose-rate irradiation with a remote a抗erloadingsystem14l. 
High-dosふrateintracavitary irradiation has achieved favorable results in patients with 
cancers of the uterine cervix and the esophagus. Bile duct and pancreatic cancers are les 
sensitive and should theoretically benefit 企omintracavitary high-dos巴圃rateirradiauon. 
Encouraging experience with RALS using 192Ir for bile duct cancer has been reportedl. 
This methud resembles ours' irithat ituses an afterloading system and that irradiation 
can be coInpleied in minutes. However， because the half-life of 192Ir is as short as 74 
days， itinvolves an economic problem that the radiatio~ source has to be frequently re-
newed. In contnist to 192Ir， 60CO has a long half-life (about 5 years); therefore， itcan be 
used for man'y patients. This is an economic advantag~・
The conveil.tional applieator designed for RALS using 60CO has a blind sac requiring 
a tube with an internal diameter of at least 4 mm  and an outside diameter of 5 mm. The 
insertion of such a large tube into the bile duct through a sheath is technically more 
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difficult. Our newly developed double lumen applicator described in. this presentation 
has an external diameter of 5 tnm， 14 Fr， one lumen acceptsa 0.035 inch wire for easi町
insertion. This also al10ws ready exchange with a smal1erdrainage tube. 
The expandablemetallic stents we're devised by Gianturco and reported by Wright2) 
et al. They have been successful1y used in laboratorγanimals with a normal biliaiγduct 
and tracheobronchial tree; normal and st巴nosedvascular system， aswel1 as in patients with 
stenoses of the vena cava， trachea， and bronchus3)何日 Itsclinical application in the 
biliary ttact has considerable pot疋ntial. Biliary endoprosthesis is advantageous in that 
it involves a low risk of infections and that it al10wsthe tatients tobathe and to re同
store their social activity. However， the problems involvedin endoprosthesis (such as 
obstruction or dislodger田 nt of the internal drainage 加 be吋)have not been s叩01加v巴吋dy戸et1臼附5
To reduce the児巴 obstructionof the internal drainage tube， a tube of larger diameter (1.2 Fr 
or more) is necessary17}. However， insertionof such a large diameter tubecausesmuch 
stress to the patient and elevates the risk of complications. Expandable metallic biliary 
endoprosthesis can solve this problem， because .the biliary tract can bekeptpatent 
using an introducer with a small diameter. The stentused for this technique iscapable 
of self-expanding; therefore， itprevents the growth of tumor and delays reobstruction. 
Furthermore， it involves hardly any risk of dislodgement. It is possible to insert another 
stent through the lumen of a stent for the purpose of increasing expandable power and 
also perform endoprosthesis. of multiple intrahepatic branches. As seen in the micro聞
scopic exarnination of autopsied Case 2， the bile duct kept its patency in spite of marked 
fibrosis in the bile duct wal1. In addition， because the stent wire is. embedded in the 
fibrous tissue of the wal1， it is unlikely that biliary stasis (for which the stent serves as a 
core) and the subsequent cholangitis occur. Our clinical experience with this technique 
in 8 cases of biliary tract cancer indicates that intracavitary irradiation combined with 
external irradiation can local1y control the tumor; that biliarγendoprosthesis with an 
expandable. metal1ic stent works to keep the bile duct patent by preventing the tumor 
regrowth and the reobstruction due to radiation fibrosis and therefore prevent 
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Legends 
Fig.1. a: A newly developed applicator for RALS， which has a double lumen， allowβinsertion 
。fa 0.035 inch wire and easy exchange with a drainage tube (arrow). A4 ci dummy 
source of 60CO (arrowhead). 
b: Picture of a patient irradiat疋dwith RALS. A 6PCO source is in日ertedto the 
tumor-affected area using the remote afterloading system. lrradiation takes only a 
few minutes. 
c: Procedure and technique of intracavitary irradiation with 60CO. i) External and 
internal drainage are performed， and the lumen is dilated up to 14 Fr diameter. 
i) Using.a 0.035 inch guide wire， thedrainage tube is exchanged with a RALS 
applicator. ii) For the simulation， a dummy radiation source is' inserted， and the 
region for irradiation is decided. iv) With the remote afterloading system， intra-
cavitary irradiation is performed moving a 60CO radiation source at an interval of 
1 cm. 
Fig. 2. a: Expandable metallic stent. 
*=Bare stent，和~=Nylon graft 
b: Procedure and technique of expandable biliary endoprosthesis. i) The introducer 
is inωS関悶附巴α白r巾.
inner syringe and t白h巴 guidewir巴 areremoved， and the stent is inserted .and advanced 
through the outer syringe using the pusher. ii) When the tip of the stent has 
arrived at the lesion， the pusher is fixed and the outer syringe is slowly removed. 
If done correctly， the stent leaves th巴 tipof the outer syringe and begins to dilate. 
iv) Aft巴ral stents have left the tip of the outer syringe and have been dilated， the 
outer syringe is exchanged with an external drainage tube. After one-week followべlp
observation and confirmation of patency， the external drainage tube is removed to 
complete the procedure of endoprosthesis. 
Fig.3. Case 1: A 68-year-old woman with gallbladder cancer. 
a: Percutaneous cholangiogram showed complete obstruction of the bile duct at the 
porta hepatis. 
b: External-internal drainage and dilatation of the tract to 14 Fr in diameter. 
c: With the guidance of a 0.035 inch wire， the drainage catheter was exchanged for 
the applicator of RALS， and then intracavitary irradiation was performed with 
movement of the radiation source at 1 cm intervals. 
d: Three days a仕erirradiation， a cholangiogram revealed the common bile duct to be 
patent with good drainage into the duodenum. 
e: The isodose distribution of intracavitary irradiation demonstrated on CT showed a 
high localized dose distribution in the tumor area. . 
f: Three days after irradiation a nylon四 coveredexpandable metallic biliary endopros開
thesis (nylon gra仕)was inserted into the co呼monbile， duct through a 12 Fr intro-
ducer. Cholangiogram opacified the common" bile duct through， the expandable 
stents. 
g: One month after placement of expandableはent，there was goo~ expan山貝without
the deformity and the dislodgement of expandabl巴 stent.
h: Two months after placement of expandable stent， CT showed marked improvement 
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with maintenance of patency of the common bile duct. 
Fig.4. Case 2: A 48-year-old woman with cholangiocarcinoma. 
a: The first PTC. Irregular stenosis is seen in themiddle to inferior area of the com司
mon bile duct. 
b: A cholangiogram from the external drainagetube after irradiation. The bile duct 
wall is smooth， and passage is good. 
c: One week after irradiation an expandable biliary endoprosthesis was inserted. 
Cholangiogram demonstrated the good passage of the common bile duct through the 
expandable stent. 
d: Autopsy specimen. Retrograde cholangiogram from the papilla vater demonstrated 
the patency of the stent-inserted area and good passage to the intrahepatic bile 
duct. 
e: Macroscopic observation of the cross section. The patency of the bile duct is kept. 
The stent wire is not seen on the surface， itis embedded in the wall. 
f: Microscopic observation. The inner surface of the duct where the stent was inserted 
is covered with thick fibrous tissue. No cancer cells are seen on the surface. 
*=Cavities where the stent wires were located. 











High“dose-rate afte~loadin~ intr~cavitary irradiation and expandable ( 153) 
metallic biliary endoprosthesis for malignant biliary obstruetion 
Fig.2. a 
Fig.2. b 
( 154) H. Y oshimura， et a1. 
Fig.3. a Fig.3. b 
Fig.3. c Fig. 3. d 
High司 dose司 rateafte~loadinJ5 i~tr~cavita!.y irradiation and expandable ( 155 ) 




( 156) H. Y oshimura， et al. 
Fig.3. g Fig.3. h 
High-dose司rateafte:loadin~ intr~cavitary irradiation and expandable ( 157 ) 
metallic biliary endoprosthesis for malignant biliary obstruction 
Fig.4. a Fig.4. b Fig.4. c 
Fig.4. d Fig.4. e Fig.4. f 
